Snapshot from Jul 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Business earnings release

Fulgent Genetics Q2 2026 Earnings Release

Analysis based on 6 articles · First reported Jul 09, 2026 · Last updated Jul 09, 2026

Sentiment
0
Attention
0
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The announcement is a routine earnings release schedule with no immediate market impact. Investors will watch for Q2 performance and any updates on therapeutic development progress.

biotechnology healthcare

Fulgent Genetics, Inc. announced that it will release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. Management will host a conference call at 4:30 PM ET to discuss results. The company is a technology-based laboratory services and therapeutic development firm focused on precision medicine.

30 Fulgent Genetics announced earnings release
stock
Fulgent Genetics is the subject of the event, announcing its Q2 2026 earnings release date.
Importance 100.0 Sentiment 0.0
exch
Fulgent Genetics is listed on Nasdaq under ticker FLGT.
Importance 10.0 Sentiment 0.0
priv
Blueshirt Group is the investor relations contact for Fulgent Genetics.
Importance 5.0 Sentiment 0.0
per
Lauren Sloane of Blueshirt Group is the investor relations contact for the event.
Importance 5.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.